Search for a Medicine

  • Medicines
 
 

Showing 221-240 of 383 matching medicines

Product listings were last updated on 16/04/2024
Trade Name Licence Number & Holder Documents
Bonviva
Solution for injection

Compare
EU/1/03/265/5-6

Atnahs Pharma Netherlands B.V.
SPC PIL IPAR EdM
Bonviva 150 mg film-coated tablets
Film-coated tablet


Generics List: Ibandronic acid 150mg Film-coated Tablets

Compare
EU/1/03/265/3-4
Authorised: 15/09/2005
Atnahs Pharma Netherlands B.V.
SPC PIL IPAR
Boostrix suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed, reduced antigen(s) content)
Suspension for injection in pre-filled syringe

Compare
PA1077/020/001
Authorised: 20/04/2001
GlaxoSmithKline (Ireland) Limited
SPC PIL
Boots Ibuprofen and Codeine 200mg / 12.8 mg film-coated tablets
Film-coated tablet

Compare
PA23081/004/001
Authorised: 17/12/2010
Taw Pharma (Ireland) Limited
SPC PIL
Bortezomib 1 mg powder for solution for injection
Powder for solution for injection

Compare
PA23142/012/001
Authorised: 02/06/2017
Morningside Healthcare (Malta) Limited
SPC PIL
Bortezomib 2.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA23142/012/003
Authorised: 22/03/2019
Morningside Healthcare (Malta) Limited
SPC PIL
Bortezomib 2.5 mg/ml solution for injection
Solution for injection

Compare
PA1774/008/001
Authorised: 19/11/2021
EVER Valinject GmbH
SPC PIL
Bortezomib 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA23142/012/002
Authorised: 02/06/2017
Morningside Healthcare (Malta) Limited
SPC PIL
Bortezomib 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA23092/003/001
Authorised: 23/09/2022
Reddy Holding GmbH
SPC PIL
Bortezomib 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA2299/057/001
Authorised: 01/04/2022
Baxter Holding B.V.
SPC PIL
Bortezomib 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA23250/003/001
Authorised: 01/04/2022
MSN Labs Europe Limited
SPC PIL
Bortezomib Accord
Powder for solution for injection

Compare
EU/1/15/1019/001
Authorised: 20/07/2015
Accord Healthcare S.L.U.
SPC PIL IPAR
Bortezomib Accord
Powder for solution for injection

Compare
EU/1/15/1019/002
Authorised: 28/05/2018
Accord Healthcare S.L.U.
SPC PIL IPAR
Bortezomib Accord
Solution for injection

Compare
EU/1/15/1019/003-006
Authorised: 23/07/2021
Accord Healthcare S.L.U.
SPC PIL IPAR
Bortezomib Biotech Pharma 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA25233/001/001
Authorised: 26/06/2020
Target Healthcare Limited
SPC PIL
Bortezomib Clonmel 2.5 mg/ml Solution for Injection
Solution for injection

Compare
PA0126/297/001
Authorised: 20/04/2018
Clonmel Healthcare Ltd
SPC PIL
Bortezomib Fresenius Kabi
Powder for solution for injection

Compare
EU/1/19/1397/001
Authorised: 14/11/2019
Fresenius Kabi Deutschland GmbH
SPC PIL IPAR
Bortezomib Hospira
Powder for solution for injection

Compare
EU/1/16/1114/001
Authorised: 22/07/2016
Pfizer Europe MA EEIG
SPC PIL IPAR
Bortezomib medac 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA0623/018/001
Authorised: 18/05/2018
medac Gesellschaft für klinische Spezialpräparate mbH
SPC PIL
Bortezomib Mylan 3.5 mg powder for solution for injection
Powder for solution for injection

Compare
PA0577/191/001
Authorised: 17/05/2019
McDermott Laboratories Ltd., T/A Gerard Laboratories
SPC PIL